学术探索
学术期刊
新闻热点
数据分析
智能评审

Statistical approaches and policies for the operations of Data and Safety Monitoring Committees

被引：8
作者：
Califf, RM [1 ]
Ellenberg, SS
机构：
[1] Duke Clin Res Inst, Durham, NC USA
[2] US FDA, Div Biostat & Epidemiol, Rockville, MD 20857 USA
来源：
AMERICAN HEART JOURNAL | 2001年 / 141卷 / 02期
关键词：
D O I：
10.1067/mhj.2001.113152
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：301 / 305
页数：5
相关论文
共 22 条
  • [1] Hirudin in acute myocardial infarction - Thrombolysis and thrombin inhibition in myocardial infarction (TIMI) 9B trial
    Antman, EM
    [J]. CIRCULATION, 1996, 94 (05) : 911 - 921
  • [2] Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction - Results from the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes (GUSTO-IIb) Trial
    Berger, PB
    Ellis, SG
    Holmes, DR
    Granger, CB
    Criger, DA
    Betriu, A
    Topol, EJ
    Califf, RM
    [J]. CIRCULATION, 1999, 100 (01) : 14 - 20
  • [3] CANNER PL, 1981, CONTROL CLIN TRIALS, V1, P363
  • [4] Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial
    Cannon, CP
    McCabe, CH
    Wilcox, RG
    Langer, A
    Caspi, A
    Berink, P
    Lopez-Sendon, J
    Toman, J
    Charlesworth, A
    Anders, RJ
    Alexander, JC
    Skene, A
    Braunwald, E
    [J]. CIRCULATION, 2000, 102 (02) : 149 - 156
  • [5] The agonising negative trend in monitoring of clinical trials
    DeMets, DL
    Pocock, SJ
    Julian, DG
    [J]. LANCET, 1999, 354 (9194) : 1983 - 1988
  • [6] Early stopping of a clinical trial when there is evidence of no treatment benefit: Protocol B-14 of the National Surgical Adjuvant Breast and Bowel Project
    Dignam, JJ
    Bryant, J
    Wieand, HS
    Fisher, B
    Wolmark, N
    [J]. CONTROLLED CLINICAL TRIALS, 1998, 19 (06): : 575 - 588
  • [7] Should data and safety monitoring boards share confidential interim data?
    Dixon, DO
    Lagakos, SW
    [J]. CONTROLLED CLINICAL TRIALS, 2000, 21 (01): : 1 - 6
  • [8] Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer
    Fisher, B
    Dignam, J
    Wolmark, N
    DeCillis, A
    Emir, B
    Wickerham, DL
    Bryant, J
    Dimitrov, NV
    Abramson, N
    Atkins, JN
    Shibata, H
    Deschenes, L
    Margolese, RG
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (22): : 1673 - 1682
  • [9] FLEMING TR, IN PRESS STAT MED
  • [10] THE WHAT, WHY AND HOW OF BAYESIAN CLINICAL-TRIALS MONITORING
    FREEDMAN, LS
    SPIEGELHALTER, DJ
    PARMAR, MKB
    [J]. STATISTICS IN MEDICINE, 1994, 13 (13-14) : 1371 - 1383
123